Familial cavernous malformations of the central nervous system. A clinical and genetic study of 15 German families;Familiäre kavernome des zentralnervensystems. Eine klinische und genetische studie an 15 Deutsche familien

Nervenarzt

Volumn 76, Issue 2, 2005, Pages 175-180

  Siegel, A M ^a   Bertalanffy, H ^b   Dichgans, J J ^c   Elger, C E ^d   Hopf, H ^e   Hopf, N ^f   Keidel, M ^g   Kleider, A ^h   Nowak, G ⁱ   Pfeiffer, R A ^j   Schramm, J ^d   Spuck, S ⁱ   Stefan, H ^j   Sure, U ^b   Baumann, C R ^a   Rouleau, G A ^k   Verlaan, D J ^k   Andermann, E ^l   Andermann, F ^l  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d UNIVERSITY OF BONN   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f Katharinenhospital Stuttgart   (Germany)

^g UNIVERSITY OF DUISBURG ESSEN   (Germany)

^h Neurologische Praxis   (Germany)

ⁱ UNIVERSITY OF LÜBECK   (Germany)

^j UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^k MCGILL UNIVERSITY   (Canada)

^l MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Cavernous malformations; CCM1; CCM2; Familial cavernous malformations; Genetics

Indexed keywords

BRAIN PROTEIN; CEREBRAL CAVERNOUS MALFORMATIONS 1 PROTEIN; CEREBRAL CAVERNOUS MALFORMATIONS 2 PROTEIN; CEREBRAL CAVERNOUS MALFORMATIONS 3 PROTEIN; GENE PRODUCT; KRET INTERACTION TRAPPED 1 PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CAVERNOUS SINUS; CEREBROVASCULAR MALFORMATION; CHROMOSOME 3Q; CHROMOSOME 7P; CHROMOSOME 7Q; FAMILIAL DISEASE; FAMILY; FEMALE; GENE LOCUS; HUMAN; INHERITANCE; MALE; MOLECULAR GENETICS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN INTERACTION; RETINA VEIN; SKIN BLOOD VESSEL;

ADULT; BRAIN; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERMANY; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PEDIGREE; POLYMORPHISM, GENETIC; PREVALENCE; PROTO-ONCOGENE PROTEINS; RISK ASSESSMENT; RISK FACTORS;

EID: 20244380723     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1779-3     Document Type: Article

References (48)

1. Bertalanffy H, Benes L, Miyazawa T et al. (2002) Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev 25:1-53
2. Brunereau L, Levy C, Laberge S et al. (2000) De novo lesions in familial form of cerebral cavernous malformations: clinical and MR features in 29 non-hispanic families. Surg Neurol 53:475-483
3. Chang DD, Wong C, Smith H et al. (1997) ICAP-1, a novel beta1 integrin cytoplasmicdomain-associated protein, binds to a conserved and functionally important NPXY sequence motif of beta1 integrin. J Cell Biol 138:1149-1157
4. Craig HD, Gunel M, Cepeda O et al. (1998) Multilocus linkage identifies two new loci for a Mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet 7:1851-1858
5. Davenport WJ, Siegel AM, Dichgans J et al. (2001) Analysis of the CCM1 gene in families segregating cerebral cavernous malformations: identification of new mutations and identification of extracranial manifestations. Neurology 56:540-543
6. Del Curling OD Jr, Kelly DL Jr, Elster AD et al. (1991) An analysis of the natural history of cavernous angiomas. J Neurosurg 75:702-708
7. Detwiller PW, Porter RW, Zabramski JM et al. (1998) Radiation-induced cavernous malformation. J Neurosurg Forum 89:167-168
8. Dubovsky J, Zabramski JM, Kurth J et al. (1995) A gene responsible for cavernous malformations of the brain maps to chromosome 7q. Hum Mol Genet 4:453-458
9. Dupré N, Verlaan DJ, Hand C et al. (2003) Linkage to the CCM2 locus and evidence of genetic heterogeneity in familial cerebral cavernous malformations. Can J Neurol Sci 30:122-128
10. Fraser FC (1997) Trinucleotide repeats not the only cause of anticipation. Lancet 350:459-460
11. Gil-Nagel A, Dubovsky J, Wilcox KJ et al. (1996) Familial cerebral cavernous angioma: a gene localized to a 15-cM interval on chromosome 7q. Ann Neurol 39:807-810
12. Günel M, Awad IA, Anson J et al. (1995) Mapping of a gene causing cerebral cavernous malformation to 7q11.2-q21. Proc Natl Acad Sci USA 92:6620-6624
13. Günel M, Awad IA, Finberg K et al. (1996) A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med 334:946-951
14. Günel M, Awad IA, Finberg K et al. (1996) Genetic heterogeneity of inherited cerebral cavernous malformation. Neurosurgery 38:1265-1271
15. Hayman LA, Evans RA, Ferrell RE et al. (1982) Familial cavernous angiomas: natural history and genetic study over a 5-year period. Am J Med Genet 11:147-160
16. Horowitz M, Kondziolka D (1995) Multiple familial cavernous malformations evaluated over three generations with MR. AJNR Am J Neuroradiol 16:1353-1355
17. Kalimo H, Kaste M, Haltia M (1997) Vascular diseases. In: Graham DI, Lantos PL (eds) Greenfield's neuropathology. Arnold, New York, pp 345-347
18. Kufs H (1928) Über die heredofamiläre Angiomatose des Gehirns und der Retina, ihre Beziehungen zueinander und zur Angiomatose der Haut. Z Neurol Psychiatrie 113:651-686
19. Labauge P, Laberge S, Brunereau L et al. (1998) Hereditary cerebral cavernous angiomas: clinical and genetic features in 57 French families. Lancet 352:1892-1897
20. Laberge-le Couteulx S, Jung HH, Labauge P et al. (1999) Truncating mutations in CCM1, encoding Krit1, cause hereditary cavernous angiomas. Nat Genet 23:189-193
21. Liquori CL, Berg MJ, Siegel AM et al. (2003) Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations. Am J Hum Genet 73:1459-1464
22. Luschka H (1854) Cavernöse Blutgeschwulst des Gehirnes. Virchows Archiv für pathologische Anatomie 6:458-470
23. Marchuk DA, Gallione CJ, Morrison LA et al. (1995) A Locus for cerebral cavernous malformations maps to chromosome 7q in 2 families. Genomics 28:311-314
24. McCormick WF (1984) Pathology of vascular malformations of the brain. In: Wilson CB, Stein BM (eds) Intracranial arteriovenous malformations, 1st edn. Williams and Wilkins, Baltimore, pp 44-63
25. Otten P, Pizzolato GP, Rilliet B et al. (1989) A propos de 131 cas d'angiomas caverneux (cavernomas) du S.N.C, repérés par l'analyse retrospective de 24535 autopsies. Neurochirurgie (Paris) 35:82-83
26. Penfield W, Ward A (1948) Calcifying epileptogenic lesions: hemangioma calcificans. Report of a case. Arch Neurol Psychiatr 60:20-36
27. Polymeropoulos MH, Hurko O, Hsu F et al. (1997) Linkage of the locus for cerebral cavernous hemangiomas to human chromosome 7q in four families of Mexican-American descent. Neurology 48:752-757
28. Rigamonti D, Hadley MN, Drayer BP et al. (1988) Cerebral cavernous malformations. Incidence and familial occurence. N Engl J Med 319:343-347
29. Robinson JR, Awad IA, Little JR (1991) Natural history of the cavernous angioma. J Neurosurg 75:709-714
30. Russell DS, Rubinstein LJ (1989) Pathology of tumours of the nervous system, 5th edn. Williams & Wilkins, Baltimore, pp 727-790
31. Sage MR, Brophy BP, Sweeney C et al. (1993) Cavernous haemangiomas (angiomas) of the brain: clinically significant lesions. Australas Radiol 37:147-155
32. Sahoo T, Johnson EW, Thomas JW et al. (1999) Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations. Hum Mol Genet 8:2325-2333
33. Serebriiskii I, Estojak J, Sonoda G et al. (1997) Association of Krev-1/rap1a with Kritl, a novel ankyrin repeat- containing protein encoded by a gene mapping to 7q21-22. Oncogene 15:1043-1049
34. Siegel AM (1998) Familial cavernous angioma: an unknown, known disease. Acta Neurol Scand 98:369-371
35. Siegel AM, Andermann E, Badhwar A et al. (1998) Anticipation in familial cavernous angioma: a study of 52 families from International Familial Cavernous Angioma Study. Lancet 352:1676-1677
36. Siegel AM, Andermann F, Badhwar A et al. (1998) Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand 98:372-376
37. Simard JM, Garcia-Bengochea F, Ballinger WE Jr et al. (1986) Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery 18:162-172
38. Squitieri F, Maglione V, Buzzi MG et al. (2000) Cavernous angiomas of the nervous system in Italy: clinical and genetic study. Neurol Sci 21:129-134
39. Sure U, Butz N, Schlegel J et al. (2001) Endothelial proliferation, neoangiogenesis and potential de novo generation of cerebral vascular malformations. J Neurosurg 94:972-977
40. Sure U, Butz N, Siegel AM et al. (2001) Treatment-induced neoangiogenesis in cerebral arteriovenous malformations. Clin Neurol Neurosurg 103:29-32
41. Verlaan DJ, Davenport WJ, Stefan H et al. (2002) Cerebral cavernous malformations: mutations in Krit1. Neurology 58:853-857
42. Verlaan DJ, Siegel AM, Rouleau GA (2002) Krit1 missense mutations lead to splicing errors. Am J Hum Genet 70:1564-1567
43. Verlaan DJ, Laurent SB, Sure U et al. (2004) CCM1 mutation screen of sporadic cases with cerebral cavernous malformations. Neurology 62:1213-1215
44. Verlaan DJ, Laurent SB, Rochefort DL et al. (2004) CCM2 mutations account for 13% of cases in a large collection of kindreds with hereditary cavernous malformations. Ann Neurol 55:757-758
45. Zabramski JM, Wascher TM, Spetzler RF et al. (1994) The natural history of familial cavernous malformation: results of an ongoing study. J Neurosurg 80:422-432
46. Zawistowski JS, Serebriiskii IG, Lee MF et al. (2002) KRIT1 association with the integrin-binding protein ICAP-1: a new direction in the elucidation of cerebral cavernous malformations (CCM1) pathogenesis. Hum Mol Genet 11:389-396
47. Zhang J, Clatterbuck RE, Rigamonti D et al. (2001) Interaction between krit1 and icap1 alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation. Hum Mol Genet 10:2953-2960
48. Zhang XA, Hemler ME (1999) Interaction of the integrin beta1 cytoplasmic domain with ICAP-1 protein. J Biol Chem 274:11-19